Top compounds associated with response to IRF6


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-05
mRNA AICAR GDSC1000 pan-cancer AAC 0.17 9e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 9e-05
mRNA Vandetanib CCLE pan-cancer AAC 0.23 0.0001
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 0.0001
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 0.0002
mRNA Doxorubicin gCSI pan-cancer AAC -0.24 0.0002
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.0002
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.17 0.0002
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.15 0.0002
Download CSV